Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bergshoeff

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2005
Increased dose of lopinavir/ritonavir compensates for efavirenz-induced drug-drug interaction in HIV-1-infected childrenAlina S Bergshoeff, Pieter L Fraaij, Jennifer Ndagijimana, et al.
Antiviral Therapy|May 4, 2005
Plasma pharmacokinetics of once- versus twice-daily lamivudine and abacavir: simplification of combination treatment in HIV-1-infected children (PENTA-13)Alina Bergshoeff, David Burger, Corrien Verweij, et al.
Circulation|January 7, 1997
Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue plasminogen activatorE A Biessen, M van Teijlingen, H Vietsch, et al.
Antiviral Therapy|August 20, 2003
Pharmacokinetics of nelfinavir in children: influencing factors and dose implicationsAlina S Bergshoeff, Pieter L A Fraaij, Annemarie M C van Rossum, et al.
Antiviral Therapy|August 3, 2007
Plasma concentrations of the HIV-protease inhibitor lopinavir are suboptimal in children aged 2 years and belowGwenda Verweel, David M Burger, Nancy L Sheehan, et al.
The Journal of Biological Chemistry|November 8, 1996
Lysine-based cluster mannosides that inhibit ligand binding to the human mannose receptor at nanomolar concentrationE A Biessen, F Noorman, M E van Teijlingen, et al.
The Journal of Antimicrobial Chemotherapy|November 13, 2004
Plasma levels of zidovudine twice daily compared with three times daily in six HIV-1-infected childrenAlina S Bergshoeff, Pieter L A Fraaij, Corrien Verweij, et al.
Antiviral Therapy|May 12, 2004
Safety and efficacy of a NRTI-sparing HAART regimen of efavirenz and lopinavir/ritonavir in HIV-1-infected childrenPieter L A Fraaij, Jennifer Neubert, Alina S Bergshoeff, et al.
The Journal of Pathology|April 19, 2008
Chromosome instability in resection margins predicts recurrence of oral squamous cell carcinomaV E Bergshoeff, A H N Hopman, I R Zwijnenberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2004
Nelfinavir plasma concentrations are low during pregnancyJeannine F J B Nellen, Igor Schillevoort, Ferdinand W N M Wit, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2005
Increased dose of lopinavir/ritonavir compensates for efavirenz-induced drug-drug interaction in HIV-1-infected childrenAlina S Bergshoeff, Pieter L Fraaij, Jennifer Ndagijimana, et al.
Antiviral Therapy|May 4, 2005
Plasma pharmacokinetics of once- versus twice-daily lamivudine and abacavir: simplification of combination treatment in HIV-1-infected children (PENTA-13)Alina Bergshoeff, David Burger, Corrien Verweij, et al.
Circulation|January 7, 1997
Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue plasminogen activatorE A Biessen, M van Teijlingen, H Vietsch, et al.
Antiviral Therapy|August 20, 2003
Pharmacokinetics of nelfinavir in children: influencing factors and dose implicationsAlina S Bergshoeff, Pieter L A Fraaij, Annemarie M C van Rossum, et al.
Antiviral Therapy|August 3, 2007
Plasma concentrations of the HIV-protease inhibitor lopinavir are suboptimal in children aged 2 years and belowGwenda Verweel, David M Burger, Nancy L Sheehan, et al.
The Journal of Biological Chemistry|November 8, 1996
Lysine-based cluster mannosides that inhibit ligand binding to the human mannose receptor at nanomolar concentrationE A Biessen, F Noorman, M E van Teijlingen, et al.
The Journal of Antimicrobial Chemotherapy|November 13, 2004
Plasma levels of zidovudine twice daily compared with three times daily in six HIV-1-infected childrenAlina S Bergshoeff, Pieter L A Fraaij, Corrien Verweij, et al.
Antiviral Therapy|May 12, 2004
Safety and efficacy of a NRTI-sparing HAART regimen of efavirenz and lopinavir/ritonavir in HIV-1-infected childrenPieter L A Fraaij, Jennifer Neubert, Alina S Bergshoeff, et al.
The Journal of Pathology|April 19, 2008
Chromosome instability in resection margins predicts recurrence of oral squamous cell carcinomaV E Bergshoeff, A H N Hopman, I R Zwijnenberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2004
Nelfinavir plasma concentrations are low during pregnancyJeannine F J B Nellen, Igor Schillevoort, Ferdinand W N M Wit, et al.
Pageof 6